Clinical features in non-cancer and cancer patients with COVID-19
| Clinical features | Non-cancer patients with COVID-19 | Cancer patients with COVID-19 | |
|---|---|---|---|
| Clinical charac teristics | Similar: | Fever (88.7%) | Fever (78% to 82.1%) |
| Cough (67.8%) | Dry cough (74% to 81%) | ||
| Nausea or vomiting (5%) | Nausea or vomiting (5.71%) | ||
| Diarrhea (3.8%)3–5 | Diarrhea (12%)5,6,14 | ||
| Different: | Fatigue (38.1%) | Fatigue (64.3%) | |
| Dyspnea (21.9%) | Dyspnea (50%) tachypnea (14.3%) | ||
| From onset to dyspnea was 8 days3–5,16 | From onset to dyspnea was 1 or 5 days for lung cancer or other cancer patients, respectively5,6 | ||
| Radiographical findings (Chest CT imaging) | Similar: | Ground-glass opacity (65%) | Ground-glass opacity (69% to 75%) |
| Patchy consolidations (50%)3,24 | Patchy consolidation (46.3%)5,14 | ||
| Different: | Air bronchogram (47%) Interlobular septal thickening (35%) Adjacent pleura thickening (32%) | Interstitial abnormal findings including reticular appearance, fibrous trips and interlobular septal thickening (14.3%) | |
| Bilateral lung involvement (51.8%)3,24 | Bilateral lung involvement (78.6% to 91%)5,14 | ||
| Laboratory find ings | Similar: | Lymphopenia (83.2%) | Lymphopenia (82.1%) |
| Leukopenia (33.7%) | Leukopenia (32.1%) | ||
| Elevated CRP (86%) | Elevated CRP (82.1%) | ||
| Elevated myoglobin (15%) | Elevated serum globulin (39.3%) | ||
| Elevated D-Dimer (36%) | Elevated D-Dimer (39.3%) | ||
| Low level of serum albumin (98%)3,4,20 | Low level of serum albumin (89.3%)5,19 | ||
| Different: | Anemia (51%) | Anemia (75%) | |
| Elevated LDH (76%) | Elevated LDH (50%) | ||
| Elevated ESR (85%)3,4,20 | Elevated ESR (57.1%)5,19 | ||
CRP, C-reactive protein; LDH, lactate dehydrogenase; ESR, erythrocyte sedimentation rate.